Table 2.
Patient no. | Tumour extension at presentation (On imaging) | SMA |
SMV/PV |
Celiac artery |
Hepatic artery |
CT response to treatment | Surgery | Comments | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Before | After | Before | After | Before | After | Before | After | |||||
1 | BR | U | U | A | A | U | U | U | U | Stable | Yes | Involvement based on EUS and intra-operative findings |
2 | LA | U | U | A | A | E | E | E | E | Stable | No | |
3 | BR | U | U | A | E | U | A | U | E | Progression | No | Pre chemo-rad exploration |
4 | LA | E | E | E | E | A | E | E | E | Progression | No | |
5 | LA | U | U | E | E | A | E | E | E | Progression | No | |
6 | BR | A | A | A | A | U | U | U | U | Stable | Yes | Pre chemo-rad exploration |
7 | BR | U | U | E | E | U | U | U | U | Stable | No | Development of Malignant ascites |
8 | LA | U | U | E | E | U | U | E | E | Stable | No | |
9 | BR | U | U | E | E | U | U | U | U | Stable | No | Poor performance status |
10 | BR | U | U | A | A | U | U | U | U | Stable | Yes | Excision and replacement of vein. |
11 | LA | U | A | E | E | E | E | E | E | Progression | No | |
12 | BR | U | U | U | E | U | U | U | U | Progression | No | Pre chemo-rad exploration. Involvement of base of mesentery precluded resection on pre-treatment exploration, Poor performance status precluded resection after treatment |
13 | BR | A | A | U | U | U | U | U | U | Stable | No | Pre chemo-rad exploration. Poor performance status precluded resection. |
14 | LA | A | A | E | E | E | E | E | E | Stable | No | |
15 | BR | U | U | A | A | U | U | U | U | Stable | Yes | Pre chemo-rad exploration |
16 | BR | U | U | A | A | U | U | U | U | Stable | Yes | Vein resection |
E, encasement; A, abutment; U, uninvolved; BR, borderline resectable; LA, locally advanced; SMA, superior mesenteric artery; NA, not available.